510(k) Report

510(k) · Cleared

Cleared

Emboliner Embolic Protection System (EPC-03)

K261715510(k) TraditionalCleared Sep 8, 2026109-day reviewClass II21 CFR 870.1251

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Emboline, Inc. · PUM Temporary Catheter, Embolic Protection, Transcatheter Intracardiac Procedures

Cleared on Sep 8, 2026 as substantially equivalent to K192460 (Boston Scientific Corporation, 2020) after a 109-day review. Its family tree reaches back 2 generations to 2017.

Decided
Sep 8, 2026
Review
109 days
Class
Class II
Product code
PUM
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN160043 (2017). No later device cites it as a predicate yet.

  1. Root · 2 generations backDEN160043 Sentinel Cerebral Protection SystemClaret Medical, Inc. · 2017
  2. 1 generation backK192460 Sentinel Cerebral Protection SystemBoston Scientific Corporation · 2020
  3. This deviceK261715 Emboliner Embolic Protection System (EPC-03)Emboline, Inc. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN160043Sentinel Cerebral Protection SystemClaret Medical, Inc.2017—
−1K192460Sentinel Cerebral Protection SystemBoston Scientific Corporation2020—
0 (this device)K261715Emboliner Embolic Protection System (EPC-03)Emboline, Inc.2026—
FIG. 1 — Lineage of K261715, 2017–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PUM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PUM device

  1. #1 K192460 Sentinel Cerebral Protection Systemscore 1.9 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K192460Sentinel Cerebral Protection System
Summary page 5
…1CFR 870.1251 Device Class: II Product Code: PUM Primary Predicate: Boston Scientific Corporation Sentinel Cerebral Protection System, K192460 Reference Device: Medtronic SpiderFX™ Embolic Protection Device, K111010 Date Prepared: May 15, 2026…
Boston Scientific Corporation2020—
†K111010Spiderfx Embolic Protection DeviceEv3, Inc.2011—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 3 companies; a new generation was cleared every 6.6 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All PUM devices

PUM Temporary Catheter, Embolic Protection, Transcatheter Intracardiac Procedures: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · PUM

1in 2020

2017: 12020: 12026 (partial year): 1
2007high 1 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PUM

Too few PUM 510(k)s in any year since 2007 to give a median.

Recalls per year · PUM

No recall names PUM since 2007.

Adverse event reports per year · PUM

49in 2025

2018: 192019: 482020: 732021: 432022: 402023: 242024: 452025: 49
2007high 73 (2020) · low 0 (2007)2025

MAUDE reports naming product code PUM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20171—00
20180—019
20190—048
20201—073
20210—043
20220—040
20230—024
20240—045
20250—049
20261—0—

What is it indicated for?

The Emboliner Embolic Protection System is indicated for use as an embolic protection device to capture and remove

embolic material during transcatheter aortic valve replacement (TAVR). Anatomical requirements for aortic diameters

and femoral access site to sinotubular junction (STJ) distance should meet the requirement as specified in the Instructions

for Use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K261715: Emboliner Embolic Protection System (EPC-03).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K261715

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026